Eagle Pharmaceuticals (EGRX)
$60.73 0.68 (1.13%)
16:37 EDT EGRX Stock Quote Delayed 15 Minutes
Previous Close $60.73
Market Cap 900.96M
PE Ratio 30.06
Volume (Avg. Vol.) 82,442
Day's Range 59.83 - 61.44
52-Week Range 36.03 - 62.33
Dividend & Yield N/A (N/A)
EGRX Stock Predictions, Articles, and Eagle Pharmaceuticals News
- From InvestorPlace
- From the Web
An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.
The second quarter is about making money without worrying about Washington or Wall Street. These seven are the "best of the best" stocks to buy for Q2.
The world was shocked by Donald Trump's surprise victory, but few equities will benefit as much as big pharma stocks.
This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why Cypress Semiconductor Corporation (CY), Eagle Pharmaceuticals Inc (EGRX) and Energy Transfer Equity LP (ETE) Are 3 of Today’s Worst Stocks
Cypress Semiconductor (CY), Eagle Pharmaceuticals (EGRX) and Energy Transfer Equity (ETE) were left out of Monday's mostly market-wide rally.
The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
If you're a fan of growth stocks and healthcare stocks ... well, these seven names would've done you well in 2015. A few of them could keep soaring.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!